Madrigal Pharmaceuticals
0 followers
MDGL
Performance
About Madrigal Pharmaceuticals
Madrigal Pharmaceuticals is a biopharmaceutical company focused on developing novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need. Its research aims to halt or reverse liver fibrosis and treat MASH to prevent progression to cirrhosis, liver failure, or transplantation. The company highlights FDA-approved treatment in MASH and communicates a commitment to advancing care for patients affected by lipid-related liver disorders. Headquartered in the United States, Madrigal emphasizes science-driven innovation and leadership in hepatology research.
Recent News
Recent Deals
No recent deals for this company.